Who is Who in Clinical Diagnostics in China (McEvoy and Farmer's Complete Guide to IVD Distribution in China), produced jointly with the firm McEvoy & Farmer, is the product of on-the-ground primary research on Chinese labs conducted in fall and winter 2008. Included in this report:

• Market Size Estimate by Major Category (Chemistry, Critical Care Chemistry, Urine Chemistry, Hematology, Flow Cytometry, Coagulation, Immunochemistry, Molecular Testing, Other IVD)
• Country Industry Overview
• Chinese Hospital Statistics
• Profiles of 42 International Diagnostic Companies with operations in China
• Profiles of 130 Domestic Diagnostic Companies
• Profiles of 24 Local Distributors, indicating the companies they distribute for

The Chinese market represents a significant opportunity for IVD diagnostic companies. But actionable information about this emerging market is often difficult to get. Only with an exhaustive, on-the-ground research team can a company truly understand the chinese market. Now, a resource is available that can make on-the-ground research available to all companies at a fraction of the cost.

Published jointly with trusted Asian IVD market experts, this Kalorama report is a complete survey of the IVD market in China today. Market size for major categories of the IVD market, products on the market, important Chinese market trends and intense company profiles are part of this exhaustive study.

This country of 1.3 billion people is now America’s sixth largest export market, and China’s economy, while showing some effects of the world recession, has been less impacted than other nations and is showing growth, although not as rapid as in recent years. A number of recent events and trends in the Chinese healthcare environment are making China an increasingly attractive market opportunity for in vitro diagnostics companies. The increasing numbers of private laboratories and expanded reference laboratories are expanding the market for tests of all kinds.

Although there are a number of challenges for diagnostic manufacturers to understand and overcome, the market for clinical diagnostics in China (both reagents and instruments) remains one of the most promising emerging markets in the world.

Related Reports:

The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)
Jul 20, 2012 - KLI3811539 - $6,500.00

The Global Market for Medical Devices, 3rd. Edition
May 2, 2012 - KLI3873247 - $2,500.00

Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
Apr 30, 2012 - KLI3871497 - $3,500.00

White Paper: Tests That Personalize Show Faster Revenue Growth
Apr 6, 2012 - KLI3826223 - $0.00

IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics)
Mar 3, 2012 - KLI2401913 - $5,995.00

Point of Care Diagnostics Bundle (POC Diagnostic Markets, POC Diagnostics for Emerging Infectious Diseases, POC Dx in Physician Office Labs)
Mar 2, 2012 - KLI1946727 - $3,995.00

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
Mar 1, 2012 - KLI6640829 - $3,795.00

Clinical Diagnostics In Mexico: Market Analysis and Participant Directory
Mar 1, 2012 - KLID6496416 - $4,500.00

The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition
Jan 1, 2012 - KLI6501843 - $3,500.00

World Market for Gastrointestinal Devices (Rigid, Flexible and Capsule Endoscopes, Bariatric Surgery, Ostomy Products, Enteral Feeding Pumps and Other Devices)
Jan 1, 2012 - KLI6710760 - $3,500.00